BMY
Bristol-Myers Squibb Company · Healthcare · Drug Manufacturers - General
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q2 2024
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 172 | +1 | 1.32B | $76.14B | +6 | −6 |
| Q1 2026 | 175 | +1 | 1.27B | $76.90B | +4 | −4 |
| Q4 2025 | 173 | +1 | 1.36B | $73.29B | +2 | n/a |
| Q3 2025 | 26 | 0 | 840.35M | $37.89B | n/a | −1 |
| Q2 2025 | 24 | +1 | 649.62M | $30.06B | +2 | −1 |
| Q1 2025 | 20 | 0 | 256.22M | $15.62B | +1 | −1 |
| Q4 2024 | 20 | -1 | 253.42M | $14.33B | n/a | −1 |
| Q3 2024 | 20 | +1 | 169.93M | $8.78B | +1 | n/a |
| Q2 2024 | 19 | n/a | 159.17M | $6.60B | n/a | n/a |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (pasif) | 42.17M | n/a | $1.75B | 0.2% | n/c | 1 | SEC ↗ ×2 |
| 2 | Norges Bank ✦ (pasif) | 32.59M | n/a | $1.35B | 0.2% | n/c | 1 | SEC ↗ |
| 3 | PRIMECAP Management ✦ | 23.50M | n/a | $975.90M | 0.7% | n/c | 1 | SEC ↗ |
| 4 | Dodge & Cox ✦ | 15.77M | n/a | $654.80M | 0.4% | n/c | 1 | SEC ↗ |
| 5 | T. Rowe Price ✦ | 15.30M | n/a | $635.43M | 0.1% | n/c | 1 | SEC ↗ ×2 |
| 6 | Citadel Advisors ✦ | 11.01M | n/a | $455.66M | 0.5% | n/c | 1 | SEC ↗ ×3 |
| 7 | Two Sigma Investments ✦ | 6.17M | n/a | $256.44M | 0.6% | n/c | 1 | SEC ↗ |
| 8 | Arrowstreet Capital ✦ | 2.92M | n/a | $121.25M | 0.1% | n/c | 1 | SEC ↗ |
| 9 | AQR Capital Management ✦ | 2.68M | n/a | $111.15M | 0.2% | n/c | 1 | SEC ↗ ×5 |
| 10 | D. E. Shaw & Co. ✦ | 2.45M | n/a | $101.92M | 0.2% | n/c | 1 | SEC ↗ ×2 |
| 11 | Millennium Management ✦ | 1.49M | n/a | $61.91M | 0.1% | n/c | 1 | SEC ↗ |
| 12 | Adage Capital Partners ✦ | 871.63K | n/a | $36.20M | 0.1% | n/c | 1 | SEC ↗ |
| 13 | Point72 Asset Management ✦ | 637.99K | n/a | $26.50M | 0.1% | n/c | 1 | SEC ↗ |
| 14 | Bridgewater Associates ✦ | 554.99K | n/a | $23.05M | 0.1% | n/c | 1 | SEC ↗ |
| 15 | Gotham Asset Management ✦ | 286.84K | n/a | $11.91M | 0.2% | n/c | 1 | SEC ↗ |
| 16 | Marshall Wace ✦ | 255.73K | n/a | $10.62M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 17 | Fisher Asset Management ✦ | 228.00K | n/a | $9.47M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Wellington Management ✦ | 166.71K | n/a | $6.92M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 19 | GAMCO Investors ✦ | 111.44K | n/a | $4.63M | 0.1% | n/c | 1 | SEC ↗ |
"Their weight" = porsi posisi dari nilai ekuitas 13F yang dilaporkan manajer tersebut: ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Tidak ada pembeli terlacak baru kuartal ini. |
Telah keluar
| Tidak ada keluar yang terlacak kuartal ini. |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 1 pemegang, 6.60K saham, $400 dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang sekuritas ini yang dilacak: jumlah kepemilikan bersama, bukan hubungan fundamental.
Pembelian di pasar terbuka (P)
Tidak ada pembelian insider di pasar terbuka dalam jendela cakupan kami.
Penjualan di pasar terbuka (S)
Officer · 6.25K lbr · $403,498
Officer · 500 lbr · $33,750
Penghargaan, eksekusi, dan pemotongan pajak tidak pernah dihitung sebagai pembelian atau penjualan di sini. Metodologi